Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Vikram Haridas"'
Autor:
Pramod Chebbi, Vineeta Shobha, Vijay K Rao, Vikram Haridas, Ramya Janardana, Benzeeta Pinto, Sharath Kumar, Abhishek Patil, Roopa Tekkatte, Manasa Salanke, K M Mahendranath
Publikováno v:
BMC Rheumatology, Vol 7, Iss 1, Pp 1-6 (2023)
Abstract Introduction We assessed the risk factors and outcome of COVID-19 in patients with autoimmune rheumatic diseases(AIRD) who contracted infection while on background treatment with tofacitinib. Methods This is a non-interventional, cross-secti
Externí odkaz:
https://doaj.org/article/0777ee33392f46a492e7174745cedd1e
Autor:
K Chanakya, Vineeta Shobha, S Chandrashekara, Sharath Kumar, Vikram Haridas, Vijay Rao, Ramesh Jois, Manisha Daware, Yogesh Singh, Shweta Singhai, Balebail G Dharmanad, Pramod Chebbi, Subramanian Ramaswamy, Ashwini Kamath, Uma Karjiigi, VikramRaj K Jain, Chethana Dharmaplaiah, Shiva Prasad, C Srinivas, Ramya Janardana, Benzeeta Pinto, Beenish Nazir, A S Harshini, Mahendranath
Publikováno v:
Indian Journal of Rheumatology, Vol 18, Iss 3, Pp 185-191 (2023)
Introduction: Comorbidities frequently accompany psoriasis and psoriatic arthritis (PsA) and add to the disease burden. We aimed to identify the comorbidity burden in patients with PsA and evaluate its impact on the disease activity measures in our g
Externí odkaz:
https://doaj.org/article/1426a6c268c14ca6bb63a27674fc4e19
Autor:
Vineeta Shobha, Chanakya Kodishala, S Chandrashekara, Sharath Kumar, Vikram Haridas, Vijay Rao, Ramesh Jois, Manisha Daware, Yogesh Preet Singh, Shweta Singhai, B G Dharmanad, Pramod Chebbi, R Subramanian, Ashwini Kamath, Uma Karjiigi, Vikramraj K Jain, Chethana Dharmapalaiah, Shiva Prasad, C Srinivas, J Ramya, Benzeeta Pinto, Beenish Nazir, Harshini, Mahendranath
Publikováno v:
Indian Journal of Rheumatology, Vol 18, Iss 2, Pp 120-125 (2023)
Introduction: Psoriatic arthritis (PsA) is a chronic inflammatory disease with significant functional impairment. Health Assessment Questionnaire-Disability Index (HAQ-DI) is a reliable and validated outcome measure for a variety of arthritides inclu
Externí odkaz:
https://doaj.org/article/dbfce11f051c4c3284f1e9788df5863f
Autor:
Abhishek Patil, K. Chanakya, Padmanabha Shenoy, S. Chandrashekara, Vikram Haridas, Sharath Kumar, Manisha Daware, Ramya Janardana, Benzeeta Pinto, Ramaswamy Subramanian, S. Nagaraj, Yogesh Preet Singh, Shweta Singhai, Ramesh Jois, Vikramraj Jain, C. Srinivasa, B. G. Dharmanand, Chethana Dharmapalaiah, K. N. Sangeetha, Vijay K. Rao, Vineeta Shobha
Publikováno v:
BMC Rheumatology, Vol 6, Iss 1, Pp 1-10 (2022)
Abstract Background We conducted this study to identify the influence of prolonged use of hydroxychloroquine (HCQ), glucocorticoids and other immunosuppressants (IS) on occurrence and outcome of COVID-19 in patients with autoimmune rheumatic diseases
Externí odkaz:
https://doaj.org/article/b17e9c77df274d7da3b6a55e132e64f2
Autor:
Chanakya Kodishala, Vineeta Shobha, S Chandrashekara, Sharath Kumar, Vikram Haridas, Vijay K R Rao, Ramesh Jois, Manisha Daware, Yogesh Preet Singh, Shweta Singhai, B G Dharmanand, Pramod Chebbi, R Subramanian, Ashwini Kamath, Uma Karjiigi, Vikram Raj K Jain, Chethana Dharmapalaiah, Shiva Prasad, C Srinivasa, Ramya Janardana, Benzeeta Pinto, Beenish Nazir, A S Harshini, K M Mahendranath
Publikováno v:
Indian Journal of Rheumatology, Vol 17, Iss 4, Pp 340-346 (2022)
Background: Clinical patterns and disease activity burden of psoriatic arthritis (PsA) varies in different parts of the world. There are limited studies from the Indian subcontinent. Aims: To study the cutaneous and articular profile of PsA and descr
Externí odkaz:
https://doaj.org/article/8b72347ee09f483a89f34b06bc9fa856
Autor:
Vineeta Shobha, K Chanakya, Vikram Haridas, Sharath Kumar, Pramod Chebbi, Benzeeta Pinto, Vikramraj Jain, Subramaniam Ramaswamy, Shiv Prasad, Abhishek Patil, Vijay K Rao, G C Yathish, B G Dharmanand, Ramesh Jois, Ashwini Kamath, Chethana Dharmapalaiah, K N Sangeeta, Ramya Janardana, C Srinivasa, A S Harshini, Nagaraj Srinivasulu, Yogesh Preet Singh, Shweta Singhai, K M Mahendranath, S Chandrashekara
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 2, Pp 164-168 (2021)
Background: Patients with autoimmune rheumatic diseases (AIRD) may be at an increased risk for COVID-19 infection and poorer outcomes when compared with the general population. We undertook this study to estimate the risk of COVID-19 infection in our
Externí odkaz:
https://doaj.org/article/1fe2fb9001924d05ac85efa656405260
Autor:
Nithin K. K, Prakash Patil, Satheesh Kumar Bhandary, Vikram Haridas, Suchetha Kumari N, Sarathkumar E, Praveenkumar Shetty
Publikováno v:
F1000Research, Vol 10 (2021)
Coronavirus disease 2019 (CoVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 has affected more than 100 million lives. Severe CoVID-19 infection may lead to acute respiratory distress syndrome and death of the patient, and is associa
Externí odkaz:
https://doaj.org/article/de99cfa3bb9a44b1a871022eedd6ff01
Autor:
Vikram Haridas, Praveenkumar Shetty, M Nirmal Kumar, K C Vasanthakumar, Kiran Haridas, Vitthal Khode, Anil Bargale
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 1, Pp 38-43 (2018)
Aim: Ankylosing spondylitis (AS) is a chronic inflammatory arthritis mainly affecting articular and extraarticular structures. AS clinical manifestations also involve sacroiliac joints and spine. Genetic factors play a key role in AS susceptibility.
Externí odkaz:
https://doaj.org/article/08b3ff887d5a42e186f717215fdbff58
Autor:
Abhishek Patil, Vineeta Shobha, Padmanabha Shenoy, Chandrashekara S, Sharath Kumar, Manisha Daware, Vikram Haridas, Ramya Janardana, Benzeeta Pinto, Chanakya Kodishala, Subramanian Ramaswamy, Nagaraj S, Vikramraj Jain, Yogesh Preet Singh, Shweta Singhai, Srinivasa C, Ramesh Jois, Vijay K Rao, Chethana Dharmapalaiah, Sangeetha KN, Dharmanand Balebail
Publikováno v:
Lupus. 32:560-564
Introduction Patients with SLE (systemic lupus erythematosus) have a higher risk of infection due to dysregulated immune system as well as long-term use of immunosuppressants (IS). This could influence the risk of COVID-19 and its outcome. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5639333383fc4c9369c6f6e93fcaf9c3
https://doi.org/10.1177/09612033231155837
https://doi.org/10.1177/09612033231155837
Autor:
Chandrashekara S, Jyoti Ranjan Parida, Archana Sonawale, Vishnu Sharma, Kaushik Basu, John Mathew, Chethana Dharmapalaiah, Girish Bhatia, Gaurav Seth, Girish Kakade, Neeraj Jain, Reena Sharma, Firdaus Fatima, Rajeshwar Nath Srivast, Romi Shah, Bankim Desai, Ajit Nalawade, Vikram Haridas, Uma Kumar, R Naidu, Roshan Pawar, Amol Aiwale, Yogesh Rane, Vinayaka Shahavi, Akhilesh Sharma
Objectives To compare the efficacy and safety of biosimilar adalimumab injection manufactured by Enzene Biosciences Ltd. with innovator adalimumab (iADA, HUMIRA®) in subjects with active ankylosing spondylitis (AS). Methods The prospective, multicen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ce1d49f51889527bdbf4129dbd4d38d
https://doi.org/10.21203/rs.3.rs-2797942/v1
https://doi.org/10.21203/rs.3.rs-2797942/v1
